| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $607,286 ) |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL157424 | Proteolysis in the Pathogenesis of ARDS | 000 | 4 | NIH | 11/12/2024 | $614,895 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R00HL161320 | RNA editing controls pulmonary endothelial pathophenotypes in pulmonary hypertension | 000 | 3 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL171850 | Bcl-2 dependent fibroblast resistance to apoptosis occurs through persistent IL-6 signaling | 000 | 1 | NIH | 10/16/2024 | $0 |
| | 2025 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL148335 | Temporal regulation of pulmonary inflammation by MyD88 alternative pre-mRNA splicing | 000 | 4 | NIH | 10/28/2024 | -$1 |
| | 2025 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL135156 | Transcriptomic and Pharmacogenetic Asthma Endotypes in Minority Children | 000 | 5 | NIH | 11/7/2024 | -$7,465 |
| | 2025 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL137995 | Biomarker of Lung Disease in African Americans | 001 | 4 | NIH | 10/17/2024 | -$27 |
| | 2025 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL137995 | Biomarker of Lung Disease in African Americans | 000 | 4 | NIH | 10/17/2024 | -$116 |
|
| Issue Date FY: 2024 ( Subtotal = $25,792,870 ) (Continued on the next page) |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R56AI180204 | Transcriptional Regulation of the Il13 Gene in Mast Cells | 001 | 1 | NIH | 6/21/2024 | $25,197 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL167956 | GM-CSF, macrophages, and susceptibility to Mycobacterium abscessus pulmonary infection | 000 | 2 | NIH | 5/4/2024 | $554,091 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | UM1AI151958 | ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | 002 | 5 | NIH | 5/24/2024 | $0 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL155325 | Contribution of pulmonary ionocytes and neuroendocrine cells to ion transport-mediated airway surface liquid maintenance | 000 | 4 | NIH | 4/11/2024 | $409,019 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | UM1AI151958 | ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | 001 | 5 | NIH | 4/25/2024 | $4,354,533 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI155749 | MDS-Associated Spliceosome Mutations Regulate Host Defense | 001 | 4 | NIH | 5/31/2024 | $53,935 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI151021 | Transcriptional Control of T Cell Function | 001 | 4 | NIH | 5/29/2024 | $41,000 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R13HL174110 | Aspen Lung Conference Pulmonary Fibrosis - focusing on the future | 000 | 1 | NIH | 3/27/2024 | $30,000 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI152037 | ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER | 000 | 5 | NIH | 3/14/2024 | $329,638 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL161238 | Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | 001 | 3 | NIH | 1/29/2024 | $896,399 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI155749 | MDS-Associated Spliceosome Mutations Regulate Host Defense | 000 | 4 | NIH | 2/20/2024 | $485,411 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI151021 | Transcriptional Control of T Cell Function | 000 | 4 | NIH | 2/22/2024 | $369,000 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL157424 | Proteolysis in the Pathogenesis of ARDS | 000 | 3 | NIH | 11/6/2023 | $622,291 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K01DK134835 | Transcriptional control of T cell function during type 1 diabetes | 000 | 1 | NIH | 12/6/2023 | $116,126 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08ES034820 | Transcriptional Responses to Wildfire Pollution in Airway Epithelial Cells Identify Genetic Risk Factors and Mechanisms of Asthma Exacerbations | 000 | 2 | NIH | 12/5/2023 | $174,528 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01ES033678 | Using Multi-Omics to Define Regulators and Drivers of Granulomatous Inflammation and Chronic Beryllium Disease | 000 | 3 | NIH | 11/29/2023 | $646,640 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI156901 | The Origin and Role of Pulmonary ILC2 Subsets in Anti-Helminth Immunity | 000 | 5 | NIH | 7/31/2024 | $553,233 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL171850 | Bcl-2 dependent fibroblast resistance to apoptosis occurs through persistent IL-6 signaling | 000 | 1 | NIH | 7/9/2024 | $156,816 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AR077511 | Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy | 000 | 5 | NIH | 3/1/2024 | $187,525 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AR077511 | Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy | 000 | 5 | NIH | 3/1/2024 | $421,206 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 00 | 1 | HRSA | 8/1/2024 | $215,581 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI150082 | Role of immunoproteasome in airway viral infection | 000 | 5 | NIH | 4/18/2024 | $555,914 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL122995 | Asthma susceptibility due to environmental programming of innate immunity in utero | 001 | 10 | NIH | 6/26/2024 | $48,295 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL122995 | Asthma susceptibility due to environmental programming of innate immunity in utero | 000 | 10 | NIH | 12/1/2023 | $543,336 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL173030 | Activation of matrix metalloproteinase-9 is essential to overcome failed fibrosis resolution | 000 | 1 | NIH | 3/4/2024 | $610,880 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL173030 | Activation of matrix metalloproteinase-9 is essential to overcome failed fibrosis resolution | 001 | 1 | NIH | 6/18/2024 | $67,876 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL140039 | Lung Macrophage Programming in Acute Lung Injury | 001 | 7 | NIH | 1/29/2024 | $855,492 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 001 | 12 | NIH | 6/21/2024 | $58,121 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL140039 | Lung Macrophage Programming in Acute Lung Injury | 002 | 7 | NIH | 6/19/2024 | $76,043 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 000 | 12 | NIH | 2/27/2024 | $653,847 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AG073317 | Loss of progenitor function accelerates lung aging | 000 | 2 | NIH | 3/4/2024 | $621,982 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R00HL161320 | RNA editing controls pulmonary endothelial pathophenotypes in pulmonary hypertension | 000 | 3 | NIH | 8/9/2024 | $249,000 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AG073317 | Loss of progenitor function accelerates lung aging | 001 | 2 | NIH | 6/28/2024 | $69,108 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL077328 | Ceramide-Induced Destruction in Emphysema | 000 | 19 | NIH | 6/6/2024 | $676,133 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI173502 | SUNBEAM Birth Cohort: Deciphering the role of early life skin dysfunction in development of the allergic march | 001 | 1 | NIH | 9/13/2024 | $129,777 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35GM137961 | Discovery of Novel Mechanisms of Action of Ubiquitin-Like Proteins in Cellular Stress Pathways | 005 | 5 | NIH | 9/10/2024 | $383,023 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21ES036375 | The Role of Airway Epithelial Complement in Chronic Beryllium Disease | 000 | 1 | NIH | 9/18/2024 | $470,500 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI173502 | SUNBEAM Birth Cohort: Deciphering the role of early life skin dysfunction in development of the allergic march | 000 | 1 | NIH | 9/6/2024 | $1,167,998 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35GM137961 | Discovery of Novel Mechanisms of Action of Ubiquitin-Like Proteins in Cellular Stress Pathways | 001 | 5 | NIH | 8/13/2024 | $414,049 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI165922 | DNA induction of neutrophilic asthma | 000 | 4 | NIH | 7/30/2024 | $462,219 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL141264 | Role of FABP5 in COPD Exacerbations | 002 | 5 | NIH | 7/29/2024 | $597,510 |
|
